cyprotex
the ADME Tox specialists
welcome to cyprotex

Investor News

December 10, 2004 - Director Shareholding

NOTIFICATION OF INTERESTS OF DIRECTORS AND CONNECTED PERSONS

1. Name of company

CYPROTEX PLC

2. Name of director

ROBERT MORRISSON ATWATER

3. Please state whether notification indicates that it is in respect of holding of the shareholder named in 2 above or in respect of a non-beneficial interest or in the case of an individual holder if it is a holding of that person's spouse or children under the age of 18 or in respect of a non-beneficial interest

2 ABOVE

4. Name of the registered holder(s) and, if more than one holder, the number of shares held by each of them (if notified)

ROBERT MORRISSON ATWATER

5. Please state whether notification relates to a person(s) connected with the director named in 2 above and identify the connected person(s)

N/A

6. Please state the nature of the transaction. For PEP transactions please indicate whether general/single co PEP and if discretionary/non discretionary

MARKET PURCHASE

7. Number of shares / amount of stock acquired

100,000

8. Percentage of issued class

0.08%

9. Number of shares/amount of stock disposed

N/A

10. Percentage of issued class

N/A

11. Class of security

ORDINARY SHARES OF 0.1 PENCE EACH

12. Price per share

9.75 PENCE

13. Date of transaction

11/10/2004

14. Date company informed

11/10/2004

15. Total holding following this notification

170,000

16. Total percentage holding of issued class following this notification

0.13%

23. Any additional information

N/A

24. Name of contact and telephone number for queries

MARK WARBURTON - 01625 505100

25. Name and signature of authorised company official responsible for making this notification

MARK WARBURTON - COMPANY SECRETARY

Date of Notification

12/10/2004

view all the latest news +
2013 archive +
2012 archive +
2011 archive +
2010 archive +
2009 archive +
2008 archive +
2007 archive +
2006 archive +
2005 archive +
2004 archive +
2003 archive +
2002 archive +
contact

Find out more about us.

Investor Relations
Anthony Baxter/Mark Warburton

Call on +44 1625 505100

contact
careerscontactlegalprivacy
This website was last updated
on 21st July 2014
This website is intended to assist investors, industry participants, customers and employees to understand Cyprotex’s global operations and ambitions.
Certain information and detail is disclosed in the interest of compliance of AIM Rule 26.